KHTRF

KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)

About KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.

Details

Daily high
$4.32
Daily low
$4.27
Price at open
$4.27
52 Week High
$4.55
52 Week Low
$3.48
Market cap
429.6M
Dividend yield
0.00%
Volume
27,538
Avg. volume
3,995
P/E ratio
144.00

KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc News

Details

Daily high
$4.32
Daily low
$4.27
Price at open
$4.27
52 Week High
$4.55
52 Week Low
$3.48
Market cap
429.6M
Dividend yield
0.00%
Volume
27,538
Avg. volume
3,995
P/E ratio
144.00